Measles virus hijacks stem cells to attack returning ovarian cancer
NCT ID NCT02068794
First seen Nov 18, 2025 · Last updated Apr 28, 2026 · Updated 22 times
Summary
This early-stage trial tests a new way to treat ovarian cancer that has come back after standard chemotherapy. Doctors take stem cells from the patient's own fat tissue, infect them with a specially modified measles virus, and inject them into the belly. The stem cells act like delivery trucks, carrying the virus directly to cancer cells to kill them. The study involves 34 adults and aims to find the safest dose and see if it helps control the disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OVARIAN SEROMUCINOUS CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Mayo Clinic in Rochester
Rochester, Minnesota, 55905, United States
Conditions
Explore the condition pages connected to this study.